{"id":3854,"date":"2019-09-24T09:38:03","date_gmt":"2019-09-24T13:38:03","guid":{"rendered":"http:\/\/groupedevonian.com\/?p=3854"},"modified":"2024-01-05T10:07:43","modified_gmt":"2024-01-05T15:07:43","slug":"devonian-annonce-la-prolongation-de-son-placement-prive","status":"publish","type":"post","link":"https:\/\/groupedevonian.com\/fr\/devonian-annonce-la-prolongation-de-son-placement-prive\/","title":{"rendered":"Devonian annonce la prolongation de son placement priv\u00e9"},"content":{"rendered":"<p style=\"text-align: center;\">COMMUNIQU\u00c9 DE PRESSE<br \/>\n<em>Pour publication imm\u00e9diate<\/em><\/p>\n<p>&nbsp;<\/p>\n<p>NE PAS DISTRIBUER AUX AGENCES DE PRESSE AM\u00c9RICAINES NI DIFFUSER AUX \u00c9TATS-UNIS<\/p>\n<h1>DEVONIAN ANNONCE LA PROLONGATION DE SON PLACEMENT PRIV\u00c9.<\/h1>\n<p>&nbsp;<\/p>\n<p><strong>Qu\u00e9bec<\/strong><strong>, Qu\u00e9bec \u2013 17 septembre 2019<\/strong>\u2013 Groupe Sant\u00e9 Devonian Inc. (\u00ab\u00a0<strong>Devonian<\/strong>\u00a0\u00bb ou la\u00a0\u00ab\u00a0<strong>Soci\u00e9t\u00e9<\/strong>\u00a0\u00bb) (TSXV: GSD) annonce qu\u2019elle a obtenu aupr\u00e8s de la Bourse de croissance TSX (la\u00a0\u00ab\u00a0Bourse\u00a0\u00bb) une prolongation de d\u00e9lai jusqu\u2019au 1<sup>er<\/sup> novembre 2019 afin de compl\u00e9ter son placement priv\u00e9 sans courtier d\u2019un produit brut cumulatif maximum de 5\u00a0000\u00a0000\u00a0$ et de 20\u00a0000\u00a0000\u00a0unit\u00e9s de la Soci\u00e9t\u00e9 (les \u00ab\u00a0<strong>Unit\u00e9s<\/strong>\u00a0\u00bb) \u00e0 un prix de 0,25\u00a0$ par Unit\u00e9 (le\u00a0\u00ab\u00a0<strong>Placement<\/strong>\u00a0\u00bb). Chaque Unit\u00e9 est compos\u00e9e d\u2019une action \u00e0 droit de vote subalterne de la Soci\u00e9t\u00e9 (une\u00a0\u00ab\u00a0<strong>Action<\/strong> <strong>\u00e0 droit de vote subalterne<\/strong>\u00a0\u00bb) et d\u2019un demi-bon de souscription d\u2019Action \u00e0 droit de vote subalterne de la Soci\u00e9t\u00e9. Chaque bon de souscription entier (un\u00a0\u00ab\u00a0<strong>Bon<\/strong> <strong>de Souscription<\/strong>\u00a0\u00bb) permet \u00e0 son d\u00e9tenteur d\u2019acqu\u00e9rir une Action \u00e0 droit de vote subalterne au prix de 0,50\u00a0$ l\u2019Action \u00e0 droit de vote subalterne, au cours de la p\u00e9riode de 24\u00a0mois suivant la cl\u00f4ture du Placement, sous r\u00e9serve que la p\u00e9riode d\u2019exercice des Bons de souscription peut-\u00eatre acc\u00e9l\u00e9r\u00e9e si les Actions \u00e0 droit de vote subalterne se n\u00e9gocient \u00e0 un prix \u00e9gal ou sup\u00e9rieur au prix de cl\u00f4ture de un (1) dollar \u00e0 la Bourse pendant dix (10) jours cons\u00e9cutifs o\u00f9 les Actions \u00e0 droit de vote subalterne sont n\u00e9goci\u00e9es. Le 21 ao\u00fbt 2019, la Soci\u00e9t\u00e9 annon\u00e7ait la cl\u00f4ture de la premi\u00e8re tranche du Placement, soit 1\u00a0260\u00a0000\u00a0unit\u00e9s de la Soci\u00e9t\u00e9, au prix de 0,25\u00a0$ l\u2019Unit\u00e9 pour un produit brut de 315\u00a0000\u00a0$. Pour plus de d\u00e9tails, veuillez-vous r\u00e9f\u00e9rer au communiqu\u00e9 de presse publi\u00e9 sur le site SEDAR \u00e0 l\u2019adresse www.sedar.com.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Au sujet de Devonian <\/strong><\/p>\n<p>Groupe Sant\u00e9 Devonian Inc. est une soci\u00e9t\u00e9 pharmaceutique botanique en stade avanc\u00e9 de d\u00e9veloppement qui emploie une strat\u00e9gie novatrice ciblant des besoins m\u00e9dicaux non combl\u00e9s. La principale strat\u00e9gie de Devonian est de d\u00e9velopper des m\u00e9dicaments d\u2019ordonnance d\u2019origine botanique d\u00e9riv\u00e9s d\u2019\u00e9l\u00e9ment v\u00e9g\u00e9tal et d\u2019algue pour le traitement des maladies inflammatoires auto-immunes incluant, mais sans s\u2019y limiter, la colite ulc\u00e9reuse et la dermatite atopique. Fond\u00e9 sur une assise de 15\u00a0ann\u00e9es de recherche, l\u2019objectif de Devonian est \u00e9galement appuy\u00e9 par les directives r\u00e9glementaires de la FDA, l\u2019agence am\u00e9ricaine des produits alimentaires et m\u00e9dicamenteux, favorisant un processus de d\u00e9veloppement de produits m\u00e9dicamenteux botaniques d\u2019ordonnance plus efficient que celui des m\u00e9dicaments d\u2019ordonnance classique. La Soci\u00e9t\u00e9 est \u00e9galement engag\u00e9e dans le d\u00e9veloppement de produits cosm\u00e9ceutiques de grande valeur, mettant \u00e0 profit la m\u00eame approche de propri\u00e9t\u00e9 utilis\u00e9e avec ses offres pharmaceutiques. Incorpor\u00e9e en 2013, Groupe Sant\u00e9 Devonian inc. a son si\u00e8ge social \u00e0 Qu\u00e9bec, Canada o\u00f9 sont \u00e9galement situ\u00e9es ses installations d\u2019extraction de pointe avec tra\u00e7abilit\u00e9 compl\u00e8te \u00ab\u00a0de la semence au comprim\u00e9\u00a0\u00bb. Sa r\u00e9cente acquisition de la division commerciale Altius Healthcare multiplie ses occasions de diversification et de croissance. Devonian est une soci\u00e9t\u00e9 cot\u00e9e en bourse de croissance TSX de Toronto (TSXV:GSD).<\/p>\n<p>Pour plus de d\u00e9tails, visitez le\u00a0<a href=\"https:\/\/groupedevonian.com\">www.groupedevonian.com<\/a>.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>\u00c9nonc\u00e9s prospectifs <\/strong><\/p>\n<p><em>Tous les \u00e9nonc\u00e9s, autres que les faits historiques, contenus dans le pr\u00e9sent communiqu\u00e9 de presse, y compris, sans s\u2019y restreindre, ceux relatifs \u00e0 l\u2019utilisation pr\u00e9vue du produit du Placement et de mani\u00e8re g\u00e9n\u00e9rale, le paragraphe \u00ab\u00a0Au sujet de Devonian\u00a0\u00bb ci-dessus, qui d\u00e9crit essentiellement les perspectives de la Soci\u00e9t\u00e9, constituent de \u00ab\u00a0l\u2019information prospective\u00a0\u00bb ou des \u00ab\u00a0\u00e9nonc\u00e9s prospectifs\u00a0\u00bb selon le sens attribu\u00e9 par certaines lois sur les valeurs mobili\u00e8res et sont fond\u00e9s sur des attentes, des estimations et des pr\u00e9visions faites en date du pr\u00e9sent communiqu\u00e9 de presse. Les \u00e9nonc\u00e9s prospectifs sont n\u00e9cessairement fond\u00e9s sur un certain nombre d\u2019estimations et d\u2019hypoth\u00e8ses qui, bien que consid\u00e9r\u00e9es comme raisonnables par la Soci\u00e9t\u00e9 au moment o\u00f9 ces \u00e9nonc\u00e9s ont \u00e9t\u00e9 formul\u00e9s, sont assujetties \u00e0 des incertitudes et \u00e0 des impr\u00e9vus importants sur les plans op\u00e9rationnel, \u00e9conomique et concurrentiel. Ces estimations et ces hypoth\u00e8ses peuvent s\u2019av\u00e9rer inexactes. Beaucoup de ces incertitudes et de ces impr\u00e9vus peuvent affecter directement ou indirectement ou pourraient faire en sorte que les r\u00e9sultats r\u00e9els diff\u00e8rent consid\u00e9rablement de ceux avanc\u00e9s ou sous-entendus dans les \u00e9nonc\u00e9s prospectifs et les \u00e9v\u00e9nements futurs. Par leur nature m\u00eame, les \u00e9nonc\u00e9s prospectifs comportent un nombre d\u2019incertitudes et de risques intrins\u00e8ques, tant g\u00e9n\u00e9raux que particuliers, et il est possible que les estimations, pr\u00e9visions, projections et autres \u00e9nonc\u00e9s prospectifs ne se mat\u00e9rialisent pas ou que les hypoth\u00e8ses ne refl\u00e8tent pas les r\u00e9sultats futurs. Les \u00e9nonc\u00e9s prospectifs sont pr\u00e9sent\u00e9s dans le but de fournir de l\u2019information sur les efforts de la direction de d\u00e9velopper des m\u00e9dicaments d\u2019ordonnance d\u2019origine botanique et, plus g\u00e9n\u00e9ralement, les attentes et les plans de la direction relatifs \u00e0 l\u2019avenir. Les lecteurs sont mis en garde contre le risque d\u2019accorder une cr\u00e9dibilit\u00e9 excessive \u00e0 ces \u00e9nonc\u00e9s prospectifs puisqu\u2019un certain nombre de facteurs de risque importants et d\u2019\u00e9v\u00e9nements futurs pourraient entra\u00eener des diff\u00e9rences sensibles entre les r\u00e9sultats r\u00e9els et les croyances, plans, objectifs, attentes, pr\u00e9visions, estimations, hypoth\u00e8ses, et intentions exprim\u00e9s dans ces \u00e9nonc\u00e9s prospectifs. Tous les \u00e9nonc\u00e9s prospectifs contenus dans le pr\u00e9sent communiqu\u00e9 de presse sont concern\u00e9s par ces mises en garde et ceux faits dans nos autres d\u00e9p\u00f4ts aupr\u00e8s des organismes canadiens de r\u00e9glementation des valeurs mobili\u00e8res. La Soci\u00e9t\u00e9 d\u00e9cline toute intention ou obligation de mettre \u00e0 jour ou de r\u00e9viser des \u00e9nonc\u00e9s prospectifs ou d\u2019expliquer une diff\u00e9rence consid\u00e9rable entre les \u00e9v\u00e9nements r\u00e9els subs\u00e9quents et ces \u00e9nonc\u00e9s prospectifs, sauf dans la mesure requise par la loi applicable.<\/em><\/p>\n<p><em>La Bourse de croissance TSX et son fournisseur de services de r\u00e9glementation (au sens attribu\u00e9 \u00e0 ce terme dans les politiques de la Bourse de croissance TSX) n\u2019assument aucune responsabilit\u00e9 quant \u00e0 la pertinence ou \u00e0 l\u2019exactitude du pr\u00e9sent communiqu\u00e9.<\/em><\/p>\n<p><strong>Contact\u00a0:<\/strong><\/p>\n<p>Dr Andr\u00e9 P. Boulet, PhD<br \/>\nPr\u00e9sident-directeur g\u00e9n\u00e9ral<br \/>\nGroupe Sant\u00e9 Devonian inc.<br \/>\nT\u00e9l\u00e9phone : (514) 248-7509<br \/>\nCourriel : <a href=\"mailto:apboulet@groupedevonian.com\" target=\"_blank\" rel=\"noopener noreferrer\">apboulet@groupedevonian.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>COMMUNIQU\u00c9 DE PRESSE Pour publication imm\u00e9diate &nbsp; NE PAS DISTRIBUER AUX AGENCES DE PRESSE AM\u00c9RICAINES NI DIFFUSER AUX \u00c9TATS-UNIS DEVONIAN ANNONCE LA PROLONGATION DE SON PLACEMENT PRIV\u00c9. &nbsp; Qu\u00e9bec, Qu\u00e9bec \u2013 17 septembre 2019\u2013 Groupe Sant\u00e9 Devonian Inc. (\u00ab\u00a0Devonian\u00a0\u00bb ou la\u00a0\u00ab\u00a0Soci\u00e9t\u00e9\u00a0\u00bb) (TSXV: GSD) annonce qu\u2019elle a obtenu aupr\u00e8s de la Bourse de croissance TSX (la\u00a0\u00ab\u00a0Bourse\u00a0\u00bb) [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[45,35],"tags":[],"class_list":["post-3854","post","type-post","status-publish","format-standard","hentry","category-2019-fr","category-communiques-de-presse"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Devonian annonce la prolongation de son placement priv\u00e9 - DEVONIAN HEALTH GROUP INC.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/groupedevonian.com\/fr\/devonian-annonce-la-prolongation-de-son-placement-prive\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Devonian annonce la prolongation de son placement priv\u00e9 - DEVONIAN HEALTH GROUP INC.\" \/>\n<meta property=\"og:description\" content=\"COMMUNIQU\u00c9 DE PRESSE Pour publication imm\u00e9diate &nbsp; NE PAS DISTRIBUER AUX AGENCES DE PRESSE AM\u00c9RICAINES NI DIFFUSER AUX \u00c9TATS-UNIS DEVONIAN ANNONCE LA PROLONGATION DE SON PLACEMENT PRIV\u00c9. &nbsp; Qu\u00e9bec, Qu\u00e9bec \u2013 17 septembre 2019\u2013 Groupe Sant\u00e9 Devonian Inc. (\u00ab\u00a0Devonian\u00a0\u00bb ou la\u00a0\u00ab\u00a0Soci\u00e9t\u00e9\u00a0\u00bb) (TSXV: GSD) annonce qu\u2019elle a obtenu aupr\u00e8s de la Bourse de croissance TSX (la\u00a0\u00ab\u00a0Bourse\u00a0\u00bb) [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/groupedevonian.com\/fr\/devonian-annonce-la-prolongation-de-son-placement-prive\/\" \/>\n<meta property=\"og:site_name\" content=\"DEVONIAN HEALTH GROUP INC.\" \/>\n<meta property=\"article:published_time\" content=\"2019-09-24T13:38:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-01-05T15:07:43+00:00\" \/>\n<meta name=\"author\" content=\"acxdev\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"acxdev\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/devonian-annonce-la-prolongation-de-son-placement-prive\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/devonian-annonce-la-prolongation-de-son-placement-prive\\\/\"},\"author\":{\"name\":\"acxdev\",\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#\\\/schema\\\/person\\\/ff9b4cc2d46ac4fb34e4f4641825f159\"},\"headline\":\"Devonian annonce la prolongation de son placement priv\u00e9\",\"datePublished\":\"2019-09-24T13:38:03+00:00\",\"dateModified\":\"2024-01-05T15:07:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/devonian-annonce-la-prolongation-de-son-placement-prive\\\/\"},\"wordCount\":1118,\"publisher\":{\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#organization\"},\"articleSection\":[\"2019\",\"Communiqu\u00e9s de presse\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/devonian-annonce-la-prolongation-de-son-placement-prive\\\/\",\"url\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/devonian-annonce-la-prolongation-de-son-placement-prive\\\/\",\"name\":\"Devonian annonce la prolongation de son placement priv\u00e9 - DEVONIAN HEALTH GROUP INC.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#website\"},\"datePublished\":\"2019-09-24T13:38:03+00:00\",\"dateModified\":\"2024-01-05T15:07:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/devonian-annonce-la-prolongation-de-son-placement-prive\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/devonian-annonce-la-prolongation-de-son-placement-prive\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/devonian-annonce-la-prolongation-de-son-placement-prive\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Devonian annonce la prolongation de son placement priv\u00e9\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/\",\"name\":\"DEVONIAN HEALTH GROUP INC.\",\"description\":\"Botanical pharmaceutical corporation\",\"publisher\":{\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#organization\",\"name\":\"Groupe Sant\u00e9 Devonian inc.\",\"alternateName\":\"Groupe Sant\u00e9 Devonian inc.\",\"url\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/groupedevonian.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/logo-devonian-2x.png\",\"contentUrl\":\"https:\\\/\\\/groupedevonian.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/logo-devonian-2x.png\",\"width\":309,\"height\":183,\"caption\":\"Groupe Sant\u00e9 Devonian inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#\\\/schema\\\/person\\\/ff9b4cc2d46ac4fb34e4f4641825f159\",\"name\":\"acxdev\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c219016bab8405cb8b5caa8f18b852d553cf083471d4e9dd4a71c4d518cc3a1c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c219016bab8405cb8b5caa8f18b852d553cf083471d4e9dd4a71c4d518cc3a1c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c219016bab8405cb8b5caa8f18b852d553cf083471d4e9dd4a71c4d518cc3a1c?s=96&d=mm&r=g\",\"caption\":\"acxdev\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Devonian annonce la prolongation de son placement priv\u00e9 - DEVONIAN HEALTH GROUP INC.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/groupedevonian.com\/fr\/devonian-annonce-la-prolongation-de-son-placement-prive\/","og_locale":"fr_FR","og_type":"article","og_title":"Devonian annonce la prolongation de son placement priv\u00e9 - DEVONIAN HEALTH GROUP INC.","og_description":"COMMUNIQU\u00c9 DE PRESSE Pour publication imm\u00e9diate &nbsp; NE PAS DISTRIBUER AUX AGENCES DE PRESSE AM\u00c9RICAINES NI DIFFUSER AUX \u00c9TATS-UNIS DEVONIAN ANNONCE LA PROLONGATION DE SON PLACEMENT PRIV\u00c9. &nbsp; Qu\u00e9bec, Qu\u00e9bec \u2013 17 septembre 2019\u2013 Groupe Sant\u00e9 Devonian Inc. (\u00ab\u00a0Devonian\u00a0\u00bb ou la\u00a0\u00ab\u00a0Soci\u00e9t\u00e9\u00a0\u00bb) (TSXV: GSD) annonce qu\u2019elle a obtenu aupr\u00e8s de la Bourse de croissance TSX (la\u00a0\u00ab\u00a0Bourse\u00a0\u00bb) [&hellip;]","og_url":"https:\/\/groupedevonian.com\/fr\/devonian-annonce-la-prolongation-de-son-placement-prive\/","og_site_name":"DEVONIAN HEALTH GROUP INC.","article_published_time":"2019-09-24T13:38:03+00:00","article_modified_time":"2024-01-05T15:07:43+00:00","author":"acxdev","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"acxdev","Dur\u00e9e de lecture estim\u00e9e":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/groupedevonian.com\/fr\/devonian-annonce-la-prolongation-de-son-placement-prive\/#article","isPartOf":{"@id":"https:\/\/groupedevonian.com\/fr\/devonian-annonce-la-prolongation-de-son-placement-prive\/"},"author":{"name":"acxdev","@id":"https:\/\/groupedevonian.com\/fr\/#\/schema\/person\/ff9b4cc2d46ac4fb34e4f4641825f159"},"headline":"Devonian annonce la prolongation de son placement priv\u00e9","datePublished":"2019-09-24T13:38:03+00:00","dateModified":"2024-01-05T15:07:43+00:00","mainEntityOfPage":{"@id":"https:\/\/groupedevonian.com\/fr\/devonian-annonce-la-prolongation-de-son-placement-prive\/"},"wordCount":1118,"publisher":{"@id":"https:\/\/groupedevonian.com\/fr\/#organization"},"articleSection":["2019","Communiqu\u00e9s de presse"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/groupedevonian.com\/fr\/devonian-annonce-la-prolongation-de-son-placement-prive\/","url":"https:\/\/groupedevonian.com\/fr\/devonian-annonce-la-prolongation-de-son-placement-prive\/","name":"Devonian annonce la prolongation de son placement priv\u00e9 - DEVONIAN HEALTH GROUP INC.","isPartOf":{"@id":"https:\/\/groupedevonian.com\/fr\/#website"},"datePublished":"2019-09-24T13:38:03+00:00","dateModified":"2024-01-05T15:07:43+00:00","breadcrumb":{"@id":"https:\/\/groupedevonian.com\/fr\/devonian-annonce-la-prolongation-de-son-placement-prive\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/groupedevonian.com\/fr\/devonian-annonce-la-prolongation-de-son-placement-prive\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/groupedevonian.com\/fr\/devonian-annonce-la-prolongation-de-son-placement-prive\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/groupedevonian.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Devonian annonce la prolongation de son placement priv\u00e9"}]},{"@type":"WebSite","@id":"https:\/\/groupedevonian.com\/fr\/#website","url":"https:\/\/groupedevonian.com\/fr\/","name":"DEVONIAN HEALTH GROUP INC.","description":"Botanical pharmaceutical corporation","publisher":{"@id":"https:\/\/groupedevonian.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/groupedevonian.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/groupedevonian.com\/fr\/#organization","name":"Groupe Sant\u00e9 Devonian inc.","alternateName":"Groupe Sant\u00e9 Devonian inc.","url":"https:\/\/groupedevonian.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/groupedevonian.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/groupedevonian.com\/wp-content\/uploads\/2022\/05\/logo-devonian-2x.png","contentUrl":"https:\/\/groupedevonian.com\/wp-content\/uploads\/2022\/05\/logo-devonian-2x.png","width":309,"height":183,"caption":"Groupe Sant\u00e9 Devonian inc."},"image":{"@id":"https:\/\/groupedevonian.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/groupedevonian.com\/fr\/#\/schema\/person\/ff9b4cc2d46ac4fb34e4f4641825f159","name":"acxdev","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/c219016bab8405cb8b5caa8f18b852d553cf083471d4e9dd4a71c4d518cc3a1c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c219016bab8405cb8b5caa8f18b852d553cf083471d4e9dd4a71c4d518cc3a1c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c219016bab8405cb8b5caa8f18b852d553cf083471d4e9dd4a71c4d518cc3a1c?s=96&d=mm&r=g","caption":"acxdev"}}]}},"_links":{"self":[{"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/posts\/3854","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/comments?post=3854"}],"version-history":[{"count":4,"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/posts\/3854\/revisions"}],"predecessor-version":[{"id":3861,"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/posts\/3854\/revisions\/3861"}],"wp:attachment":[{"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/media?parent=3854"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/categories?post=3854"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/tags?post=3854"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}